Atmospheric Chemistry

T.J. Wallington, M.D. Hurley, J.C. Ball, E.W. Kaiser, "Atmospheric chemistry of hydro-fluorocarbon 134a: Fate of the alkoxy radical CF3CFHO," Environmental Science & Technology, 26:1318-24, 1992. Tim Wallington (Ford Motor Co., Dearborn, Mich.): "Recognition of the adverse impact of chlorofluoro-carbons (CFCs) on stratospheric ozone has prompted an international effort to replace CFCs with environmentally acceptable alternatives. Hy

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Tim Wallington (Ford Motor Co., Dearborn, Mich.): "Recognition of the adverse impact of chlorofluoro-carbons (CFCs) on stratospheric ozone has prompted an international effort to replace CFCs with environmentally acceptable alternatives. Hydrofluorocarbons (HFCs) are an important class of CFC replacements. HFC-134a (CF3CFH2) is a replacement for CFC-12 (CF2Cl2) in domestic refrigeration and automobile air conditioning units. Investment in HFC- 134a is on the order of a billion dollars! "Prior to the large-scale industrial use of HFC-134a, the environmental impact of its release into the atmosphere needs consideration. HFC-134a does not contain chlorine and so has no ozone-depletion potential associated with the well-established chlorine catalytic cycles. However, there has been speculation that CF3 radicals (formed during the atmospheric degradation of HFC-134a) could impact stratospheric ozone. To define the environmental impact of HFC-134a requires assessment of its ability to impact stratospheric ozone, contribute to potential global warming, and produce noxious degradation products. This ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies